M
Marwou de Kock
Researcher at University of Cape Town
Publications - 27
Citations - 1714
Marwou de Kock is an academic researcher from University of Cape Town. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 18, co-authored 26 publications receiving 1496 citations.
Papers
More filters
Journal ArticleDOI
Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load
Cheryl L. Day,Cheryl L. Day,Deborah Abrahams,Lesedi Lerumo,Esme Janse van Rensburg,Lynnett Stone,Terrence O’rie,Bernadette Pienaar,Marwou de Kock,Gilla Kaplan,Hassan Mahomed,Keertan Dheda,Willem A. Hanekom +12 more
TL;DR: In this article, the authors compared M. tuberculosis-specific T cell-associated cytokine production and proliferative capacity in peripheral blood from adults with progressively higher mycobacterial loads.
Journal ArticleDOI
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults
Brian Abel,Michele Tameris,Nazma Mansoor,Sebastian Gelderbloem,Jane Hughes,Deborah Abrahams,Lebohang Makhethe,Mzwandile Erasmus,Marwou de Kock,Linda van der Merwe,Anthony Hawkridge,Ashley Veldsman,Mark Hatherill,Giulia Schirru,Maria Grazia Pau,Jenny Hendriks,Gerrit Jan Weverling,Jaap Goudsmit,Donata Sizemore,J. Bruce McClain,M.A. Goetz,Jacqueline Gearhart,Hassan Mahomed,Gregory D. Hussey,Jerald C. Sadoff,Willem A. Hanekom +25 more
TL;DR: Vaccination with AERAS-402 is safe and immunogenic in healthy adults, and the immunity induced by the vaccine appears promising: polyfunctional T cells are thought to be important for protection against intracellular pathogens such as Mycobacterium tuberculosis, and evidence is accumulating that CD8(+) T Cells are also important.
Journal ArticleDOI
Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation.
Andreia Soares,Lerisa Govender,Jane Hughes,Wendy Mavakla,Marwou de Kock,Charlene Barnard,Bernadette Pienaar,Esme Janse van Rensburg,Gail Jacobs,Gloria Khomba,Lynnette Stone,Brian Abel,Thomas J. Scriba,Willem A. Hanekom +13 more
TL;DR: The data suggest that intracellular Ki67 expression provides a specific, quantitative and reproducible measure of antigen-specific T cell proliferation in vitro.
Journal ArticleDOI
Longitudinal Changes in CD4+ T-Cell Memory Responses Induced by BCG Vaccination of Newborns
Andreia Soares,Cheong K. C. Kwong Chung,Terry Choice,E. Jane Hughes,Gail Jacobs,Esme Janse van Rensburg,Gloria Khomba,Marwou de Kock,Lesedi Lerumo,Lebohang Makhethe,Mbulelo H. Maneli,Bernadette Pienaar,Erica Smit,Nontobeko G. Tena-Coki,Leandre van Wyk,W. Henry Boom,Gilla Kaplan,Thomas J. Scriba,Willem A. Hanekom +18 more
TL;DR: It is suggested that boosting of BCG-primed CD4 T cells with heterologous tuberculosis vaccines may be best after 14 weeks of age, once an established memory response has developed.
Journal ArticleDOI
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
Cheryl L. Day,Michele Tameris,Nazma Mansoor,Michele van Rooyen,Marwou de Kock,Hennie Geldenhuys,Mzwandile Erasmus,Lebohang Makhethe,E. Jane Hughes,Sebastian Gelderbloem,Anne Bollaerts,Patricia Bourguignon,Joe Cohen,Marie-Ange Demoitié,Pascal Mettens,Philippe Moris,Jerald C. Sadoff,Anthony Hawkridge,Gregory D. Hussey,Hassan Mahomed,Opokua Ofori-Anyinam,Willem A. Hanekom +21 more
TL;DR: M72/AS01 is clinically well tolerated in Mtb-infected and -uninfected adults, induces high frequencies of multifunctional T cells, and boosts distinct T-cell responses primed by natural Mtb infection.